Condensed Statement of Cash Flows (Unaudited)	9 Months Ended
	Sep. 30, 2020 USD ($)
Cash Flows from Operating Activities:
Net loss	$ (83,615)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account	(1,386)
Changes in operating assets and liabilities:
Prepaid expenses	(240,442)
Accounts payable and accrued expenses	25,330
Net cash used in operating activities	(300,113)
Cash Flows from Investing Activities:
Investment of cash in Trust Account	(230,000,000)
Net cash used in investing activities	(230,000,000)
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid	226,000,000
Proceeds from sale of Placement Units	5,400,000
Proceeds from collection of stock subscription receivable from stockholder	25,000
Proceeds from promissory note – related party	75,000
Repayment of promissory note – related party	(75,000)
Payment of offering costs	(433,916)
Net cash provided by financing activities	230,991,084
Net Change in Cash	690,971
Cash – Beginning of period
Cash – End of period	690,971
Non-Cash investing and financing activities:
Initial classification of common stock subject to possible redemption	216,189,340
Change in value of common stock subject to possible redemption	(83,000)
Deferred underwriting fee payable	$ 9,800,000